CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-09 | Stilwell McDavid Chief Financial Officer | Purchase | +3,700 | $13.42 | $50K | 35,118 |
| 2014-11-12 | HEALY JAMES Director | Purchase | +425,926 | $13.50 | $5.8M | 2,557,759 |
| 2014-11-12 | LILLY ELI & CO Former 10% Owner | Purchase | +164,963 | $13.50 | $2.2M | 3,042,019 |
Page 1 of 1 · 3 trades